论文部分内容阅读
Objectives Genetic polymorphism of human myeloperoxidase (MPO)-463G/A has been implicated to alter the risk of coronary artery disease (CAD), but the results are controversial.To improve the reliability of the conflicting results, we conducted a meta-analysis of studies relating the MPO-463G/A polymorphism with the risk of CAD.